Colitis, Ulcerative Clinical Trials in Southlake, Texas

4 studies are recruiting for colitis, ulcerative in Southlake, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

    Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medicine designed to treat active, moderate to severe Crohn's disease (CD) and ulcerative colitis (UC). An extension study is a type of study where people who received tulisokibart in …

    Stage
    Phase 3
    Ages
    Any age
    Site
    GI Alliance - Southlake ( Site 0298), Southlake, Texas
    Locations
    37 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06651281 on ClinicalTrials.gov

  2. A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

    The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the co…

    Stage
    Phase 3
    Ages
    12 and older
    Site
    GI Alliance Southlake, Southlake, Texas
    Locations
    401 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07196748 on ClinicalTrials.gov

  3. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

    This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) m…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Site 008, Southlake, Texas
    Locations
    267 in total
    Run by
    Spyre Therapeutics, Inc.

    See if you can join NCT07012395 on ClinicalTrials.gov

  4. An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

    The purpose of this observational study is to learn about the effects of etrasimod as a treatment for adult patients with moderate to severe ulcerative colitis. Patients will be treated according to standard of care and will only be included in the study if etrasimod is the best treatment of choice…

    Stage
    Not phased
    Ages
    18 to 64
    Site
    GI Alliance Research, Southlake, Texas
    Locations
    28 in total
    Run by
    Pfizer

    See if you can join NCT06398626 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.